Gene ontology annotations for GRB2 |
|
Experiment description of studies that identified GRB2 in exosomes |
1 |
Experiment ID |
79 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD81|MHCII
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
Authors |
Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W. |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
2 |
Experiment ID |
80 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD81|MHCII
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
Authors |
Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W. |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
3 |
Experiment ID |
81 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD81|MHCII
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
Authors |
Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W. |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
4 |
Experiment ID |
207 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
5 |
Experiment ID |
208 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
6 |
Experiment ID |
209 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
7 |
Experiment ID |
236 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✔
HSP90B1
|
EV Negative markers |
✔
qNano
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
MHCC97L |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
8 |
Experiment ID |
237 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✔
HSP90B1
|
EV Negative markers |
✔
qNano
|
EV Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocytes |
Sample name |
MIHA |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RNA Sequencing |
|
|
9 |
Experiment ID |
211 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix
|
EV Cytosolic markers |
✔
EpCAM|TFRC
|
EV Membrane markers |
✔
cytochrome c|GOLGA2
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K. |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
10 |
Experiment ID |
212 |
ISEV standards |
✔
CEM
|
EV Biophysical techniques |
✔
TSG101|Alix
|
EV Cytosolic markers |
✔
EpCAM|TFRC
|
EV Membrane markers |
✔
Cytochrome C|GOLGA2
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K. |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
11 |
Experiment ID |
231 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
Alix
|
EV Cytosolic markers |
✔
CD63|CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
12 |
Experiment ID |
232 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
13 |
Experiment ID |
233 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
14 |
Experiment ID |
275 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix|RAB5A
|
EV Cytosolic markers |
✔
CD9|CD82|CD63|CD81
|
EV Membrane markers |
✔
AIF
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
15 |
Experiment ID |
274 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix|RAB5A
|
EV Cytosolic markers |
✔
CD9|CD82|CD63|CD81
|
EV Membrane markers |
✔
AIF
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
16 |
Experiment ID |
217 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
CD81|CD9|CD63
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O. |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
17 |
Experiment ID |
63 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
AQP2
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
Protein-protein interactions for GRB2 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
MTA1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
AXL |
558 |
Affinity Capture-MS |
|
Homo sapiens |
Far Western |
|
Homo sapiens |
|
3 |
CALD1 |
|
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
HNRNPC |
3183 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
ITGA2B |
3674 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
6 |
ETV6 |
|
Affinity Capture-Western |
|
Homo sapiens |
Far Western |
|
Homo sapiens |
|
7 |
SHC1 |
6464 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
8 |
PTPN22 |
|
Affinity Capture-Western |
|
Homo sapiens |
|
9 |
DAG1 |
1605 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
10 |
SGCA |
|
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
RACGAP1 |
29127 |
Affinity Capture-MS |
|
Homo sapiens |
|
12 |
CD72 |
|
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
KRT17 |
3872 |
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
CRK |
1398 |
Reconstituted Complex |
|
Homo sapiens |
Far Western |
|
Homo sapiens |
|
15 |
ADRB2 |
|
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
16 |
CD2AP |
23607 |
Invitro |
|
Homo sapiens |
|
17 |
CLYBL |
|
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
FLT3 |
|
Invivo |
|
Homo sapiens |
|
19 |
SOCS1 |
|
Reconstituted Complex |
|
Homo sapiens |
|
20 |
PSMD10 |
5716 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
PTPN1 |
5770 |
Invivo |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
SH2B1 |
25970 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
23 |
FGFR3 |
2261 |
Invivo |
|
Homo sapiens |
|
24 |
RALGPS1 |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
PTPN12 |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
26 |
WAS |
7454 |
Affinity Capture-Western |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
27 |
USP6NL |
9712 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
28 |
TRAT1 |
50852 |
Reconstituted Complex |
|
Homo sapiens |
|
29 |
ZAP70 |
7535 |
Affinity Capture-Western |
|
Homo sapiens |
|
30 |
ERBB3 |
2065 |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
IQGAP1 |
8826 |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
MUC1 |
4582 |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
33 |
SRC |
6714 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
KHDRBS1 |
10657 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
35 |
SYK |
6850 |
Invitro |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
36 |
MAPK14 |
1432 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
ADA |
100 |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
PLCG1 |
5335 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
39 |
TOM1L1 |
10040 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
40 |
MST1R |
4486 |
Invivo |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
41 |
WASL |
8976 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
42 |
DOCK1 |
1793 |
Reconstituted Complex |
|
Homo sapiens |
Co-fractionation |
|
Homo sapiens |
|
43 |
CD28 |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
44 |
USP8 |
|
Reconstituted Complex |
|
Homo sapiens |
|
45 |
DNM1 |
1759 |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
46 |
PXN |
|
Reconstituted Complex |
|
Homo sapiens |
|
47 |
ERBB2 |
2064 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
48 |
FGFR1 |
2260 |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
PDGFRA |
|
Affinity Capture-Western |
|
Homo sapiens |
|
50 |
PTPRC |
5788 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
51 |
PRNP |
5621 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
CDKN1B |
1027 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
TFAP2A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
KRT8 |
3856 |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
IRS4 |
8471 |
Affinity Capture-Western |
|
Homo sapiens |
|
56 |
KIT |
3815 |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
57 |
FASLG |
356 |
Affinity Capture-Western |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
58 |
VAV1 |
7409 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
NCKIPSD |
51517 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
60 |
MAPK12 |
|
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
61 |
ITGA6 |
3655 |
Invivo |
|
Homo sapiens |
|
62 |
PDE6G |
|
Reconstituted Complex |
|
Homo sapiens |
|
63 |
PDGFRB |
5159 |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
64 |
TUB |
|
Invitro |
|
Homo sapiens |
|
65 |
SOCS7 |
|
Invitro |
|
Homo sapiens |
|
66 |
CBL |
867 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
67 |
HTT |
3064 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
68 |
SNTA1 |
6640 |
Invivo |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
69 |
SH3BP2 |
|
Reconstituted Complex |
|
Homo sapiens |
|
70 |
CRKL |
1399 |
Invivo |
|
Homo sapiens |
|
71 |
PTK2B |
2185 |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
|
72 |
SYNCRIP |
10492 |
Reconstituted Complex |
|
Homo sapiens |
|
73 |
DCTN1 |
1639 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
74 |
REPS2 |
|
Reconstituted Complex |
|
Homo sapiens |
|
75 |
PIK3R1 |
5295 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
76 |
EPOR |
|
Reconstituted Complex |
|
Homo sapiens |
|
77 |
RAPGEF1 |
2889 |
Affinity Capture-Western |
|
Homo sapiens |
|
78 |
SOS1 |
|
Invivo |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
| | |